×
<- Back

Management of radioiodine-refractory differentiated thyroid carcinoma (RAI-R DTC)

  • : Sydney NSW 2000

This case study-based activity will take approximately one hour to complete and will focus on patient selection for, and practical aspects of, tyrosine kinase inhibitors in RAI-R DTC.

By the end of this activity, participants will be able to:

  • Outline the importance of identifying patients with radioiodine-refractory differentiated thyroid carcinoma.
  • Discuss the potential benefits of initiating tyrosine kinase inhibitors.
  • Summarise the practical aspects of using tyrosine kinase inhibitors, including management of possible side effects.
Delivery
Title
Management of radioiodine-refractory differentiated thyroid carcinoma (RAI-R DTC)
Interest Areas / Topics Covered
Cancer, Medical Education, Oncology
Location
Provider Type
Education Provider
Duration
1 hour
CPD Points
One Category 1 credit
Price
Free
Location
Sydney NSW 2000
Posted By
Contact Phone
Log in into view this field.
Reference
751320190125
443 Views
HealthcareLink